Skip to content

Effect of Oliceridine on Tracheal Extubation Responses: A Randomized Controlled Trial

Effect of Oliceridine on Tracheal Extubation Responses: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110987
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic surgery under general anesthesia with tracheal intubation

Interventions

Group O:2mg oxelidine is configured to 5ml
Group S:0.9% saline 5ml

Sponsors

The First People's Hospital of Guiyang City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with ASA 1-3 grade, aged over 18 years, and requiring laparoscopic surgery under general anesthesia with tracheal intubation.

Exclusion criteria

Exclusion criteria: There are absolute or relative contraindications for general anesthesia; combined with severe heart, liver, or kidney dysfunction; having a history of mental illness or abuse of opioid analgesics; having high-risk factors for aspiration; diagnosed with chronic obstructive pulmonary disease or asthma; having a recent history of respiratory infection; having cognitive dysfunction; body mass index (BMI) > 35 kg/m^2; expected difficulty in tracheal intubation; expected surgical duration exceeding 3 hours; intraoperative blood loss exceeding 20%; patients who need mechanical ventilation support after surgery.

Design outcomes

Primary

MeasureTime frame
The number of patients whose tube removal quality score was greater than 2 during tube removal;

Secondary

MeasureTime frame
The intraoperative dosage of rocuronium bromide;The intraoperative dosage of sufentanil;Surgical duration;Resuscitation room stay time;The placement status of the drainage tube and the urinary catheter;The "eye-opening time" is defined as the period from when sevoflurane administration stops until the subject can open their eyes in response to verbal stimulation.;The extubation time is defined as the period of time between the cessation of sevoflurane administration and the removal of the endotracheal tube.;Heart rate;Systolic blood pressure;Diastolic blood pressure;Arterial pressure;The highest score for sedation during the PACU period after extubation;The number of patients with a VAS pain score of 4 or higher in the resuscitation room after extubation;The number and dosage of cardiovascular active drugs, tramadol and metoclopramide used after the administration of Oseliadin;The lowest respiratory rate during the PACU period after extubation;Complications after extubation (including nausea and vomiting score, hypoxemia, apnea, aspiration, severe straining, chills, dizziness, tracheal and laryngeal spasm, extubation failure, re-intubation rate, sore throat and hoarseness);Postoperative 24-hour recovery quality (assessed using the Quality of Life Questionnaire (QoR-15));Postoperative 24-hour pain VAS score;The maximum VAS score for pain within 24 hours after the operation;The number of patients using rescue analgesics and antiemetics in the hospital ward;

Countries

China

Contacts

Public ContactZhang Jun

The First People's Hospital of Guiyang City

39194100@qq.com+86 180 0850 8821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026